France · Delayed Price · Currency is EUR Europlasma Statistics
Total Valuation
Europlasma has a market cap or net worth of EUR 4,270. The enterprise value is 9.70 million.
| Market Cap | 4,270 |
| Enterprise Value | 9.70M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Europlasma has 5.34 million shares outstanding.
| Current Share Class | 5.34M |
| Shares Outstanding | 5.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +71.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66
| Current Ratio | 0.66 |
| Quick Ratio | 0.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.00 |
| Interest Coverage | -5.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.94% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -1,030.69% |
| Weighted Average Cost of Capital (WACC) | 32.42% |
| Revenue Per Employee | 98,764 |
| Profits Per Employee | -49,914 |
| Employee Count | 713 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 2.23 |
Taxes
| Income Tax | -678,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.99% in the last 52 weeks. The beta is -88.92, so Europlasma's price volatility has been lower than the market average.
| Beta (5Y) | -88.92 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 35.66 |
| Average Volume (20 Days) | 38,913,813 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Europlasma had revenue of EUR 70.42 million and -35.59 million in losses. Loss per share was -94.56.
| Revenue | 70.42M |
| Gross Profit | 30.20M |
| Operating Income | -29.52M |
| Pretax Income | -38.61M |
| Net Income | -35.59M |
| EBITDA | -39.60M |
| EBIT | -49.07M |
| Loss Per Share | -94.56 |
Balance Sheet
The company has 7.46 million in cash and 20.26 million in debt, with a net cash position of -12.81 million or -2.40 per share.
| Cash & Cash Equivalents | 7.46M |
| Total Debt | 20.26M |
| Net Cash | -12.81M |
| Net Cash Per Share | -2.40 |
| Equity (Book Value) | -24.34M |
| Book Value Per Share | -3.98 |
| Working Capital | -23.31M |
Cash Flow
In the last 12 months, operating cash flow was -14.89 million and capital expenditures -5.46 million, giving a free cash flow of -20.35 million.
| Operating Cash Flow | -14.89M |
| Capital Expenditures | -5.46M |
| Depreciation & Amortization | 7.86M |
| Net Borrowing | 22.01M |
| Free Cash Flow | -20.35M |
| FCF Per Share | -3.81 |
Margins
Gross margin is 42.89%, with operating and profit margins of -41.91% and -50.54%.
| Gross Margin | 42.89% |
| Operating Margin | -41.91% |
| Pretax Margin | -54.83% |
| Profit Margin | -50.54% |
| EBITDA Margin | -56.24% |
| EBIT Margin | -69.68% |
| FCF Margin | n/a |
Dividends & Yields
Europlasma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -833,466.04% |
| FCF Yield | -476,674.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 7, 2025. It was a reverse split with a ratio of 0.0004.
| Last Split Date | Oct 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0004 |
Scores
Europlasma has an Altman Z-Score of -5.73 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.73 |
| Piotroski F-Score | 2 |